Dara BioSciences begins diabetes drug study
The study is designed to determine the safety and pharmacokinetics of multiple ascending oral doses of DB959Na in both male and female subjects. The study results are estimated
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.